Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its operations in the U.S.

The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to ...

NHS England has struck a deal with pharmaceutical corporation Novartis to maintain GP access to inclisiran at the same price ...

A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

It's unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...

Richard Lafayette, MD, FACP, Stanford University Medical Center, explains the significance of this second approval in a month for proteinuria reduction.

Novartis commits $23 billion to expand U.S. manufacturing and R&D with 10 new facilities, aiming to produce all key U.S.

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

Photo: Alamy Novartis announced on Thursday that it will invest $23 billion in the U.S. over the next five years. The ...

Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The ...